Disc Medicine (IRON) earnings, Nov 5, 2026: EPS +14%, stock −5.8%
In brief
Disc Medicine reported on Nov 5, 2026. Earnings per share changed +14% year over year, 6.3% above the estimate; revenue 0%. The stock opened with a −0.3% gap and closed the day −5.8% (Nov 5, 2026). The stock is now 21.1% below its 52-week high, −11.1% over 12 months.
EPS vs estimate+6.3%
EPS, YoY+14%
Revenue, YoY0%
Gap · day−0.3% · −5.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −1.0% | −2.8% |
| Nov 5, 2026 | −0.3% | −5.8% |
Next-quarter estimates, ratings and the IRON chart are in the terminal.
Open the terminalFAQ
When is Disc Medicine's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Disc Medicine stock react to the report?
Opening gap −0.3%, day's result −5.8%.
Did Disc Medicine's earnings grow?
Earnings per share rose 14% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.